By Joyclyn Wea
April 14, 2026
Liberian women’s health advocates have cautiously welcomed a government announcement that it is going to more closely regulate Misoprostol, a drug widely used to cause a medical abortion or to provide care for women facing life-threatening conditions during and after pregnancy. But they warn that the regulation must not limit access to women trying to access safe health care options.
Last week, the Ministry of Health announced that misoprostol should be sold only with a valid prescription and dispensed under the supervision of a licensed pharmacist or another authorized health worker. The ministry also says it would increase inspections, check supply chains, verify prescribers, and investigate illegal sales.